Redwood City, CA · Founded 2012 · Privately Held (backing)
Developer of small molecule antivirals designed to improve health outcomes for patients suffering from diseases caused by HPV and other viruses. Antiva Biosciences is based in Redwood City, CA and was founded in 2012. Its last known valuation is $123 million. It has raised $145 million across 4 recorded rounds; the latest was a $38.5 million early-stage round in Apr 2023.
Last price · $/share
—
Implied valuation
$123.0M
Total raised
$144.8M
Last round
Early Stage VC
Apr 2023
Team — not yet on record
No current team members for Antiva Biosciences are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Antiva Biosciences with a free account
·The complete investor list: 21 names
·Watch Antiva Biosciences: the Monday email on marks, rounds and moves
